139 related articles for article (PubMed ID: 11680989)
1. [Evaluation of non-surgical therapy for the malignant lymphomas located mainly in the stomach and duodenum].
Tari A; Asaoku H; Tani H; Kashiwado K; Kurihara K; Fujihara M; Yoshino T
Nihon Shokakibyo Gakkai Zasshi; 2001 Oct; 98(10):1154-63. PubMed ID: 11680989
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and therapeutic management of gastric lymphomas].
Grau E; Perella M; Gómez A; Pastor E; Mirabet MD; García F; Ibáñez JL; Aguiló J
Sangre (Barc); 1996 Apr; 41(2):109-14. PubMed ID: 9045350
[TBL] [Abstract][Full Text] [Related]
3. Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study.
Willich NA; Reinartz G; Horst EJ; Delker G; Reers B; Hiddemann W; Tiemann M; Parwaresch R; Grothaus-Pinke B; Kocik J; Koch P
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):895-901. PubMed ID: 10705011
[TBL] [Abstract][Full Text] [Related]
4. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma.
Pinotti G; Zucca E; Roggero E; Pascarella A; Bertoni F; Savio A; Savio E; Capella C; Pedrinis E; Saletti P; Morandi E; Santandrea G; Cavalli F
Leuk Lymphoma; 1997 Aug; 26(5-6):527-37. PubMed ID: 9389360
[TBL] [Abstract][Full Text] [Related]
5. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary?
Raderer M; Chott A; Drach J; Montalban C; Dragosics B; Jäger U; Püspök A; Osterreicher C; Zielinski CC
Ann Oncol; 2002 Jul; 13(7):1094-8. PubMed ID: 12176789
[TBL] [Abstract][Full Text] [Related]
7. Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy.
Alpen B; Kuse R; Parwaresch R; Müller-Hermelink HK; Stolte M; Neubauer A
J Clin Oncol; 2004 Aug; 22(15):3039-45. PubMed ID: 15284253
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
Alpen B; Röbbecke J; Wündisch T; Stolte M; Neubauer A
Ann Hematol; 2001; 80 Suppl 3():B106-7. PubMed ID: 11757689
[TBL] [Abstract][Full Text] [Related]
9. Multimodality Treatment of Gastric Lymphoma.
Ikoma N; Badgwell BD; Mansfield PF
Surg Clin North Am; 2017 Apr; 97(2):405-420. PubMed ID: 28325194
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
[TBL] [Abstract][Full Text] [Related]
11. [Nutritional and defunctionalized jejunostomy in the chemotherapeutic treatment of gastric non-Hodgkin's lymphoma. Preliminary experience].
Messinetti S; Martelli M; Giacomelli L; Brescia A; Miglietta AM; Pulcini A; Finizio R; Porcelli C
Ann Ital Chir; 1993; 64(3):295-300. PubMed ID: 7509128
[TBL] [Abstract][Full Text] [Related]
12. Low-grade MALT lymphoma of the stomach: a review of treatment options.
Schechter NR; Yahalom J
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1093-103. PubMed ID: 10725618
[TBL] [Abstract][Full Text] [Related]
13. [Recent progress in the management of malignant lymphoma].
Ohnishi K
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1074-8. PubMed ID: 9239159
[TBL] [Abstract][Full Text] [Related]
14. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
15. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
Velasquez WS; McLaughlin P; Fuller LM; Allen PK; Tucker SL; Swan F; Rodriguez MA; Hagemeister FB; Cabanillas FF
Cancer; 1994 May; 73(9):2408-16. PubMed ID: 7513251
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of gastric lymphoma after stomach conserving treatment.
Fischbach W
Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):71-7. PubMed ID: 20206110
[TBL] [Abstract][Full Text] [Related]
18. Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma.
Avilés A; Neri N; Nambo MJ; Huerta-Guzman J; Cleto S
Med Oncol; 2006; 23(2):295-300. PubMed ID: 16720930
[TBL] [Abstract][Full Text] [Related]
19. [Gastric malignant lymphoma].
Yoshita H; Sugiyama T
Nihon Rinsho; 2012 Jul; 70(7):1253-62. PubMed ID: 22844813
[TBL] [Abstract][Full Text] [Related]
20. [Primary MALT-type lymphoma of the breast].
Rafel M; Esteve J; Cervantes F; Velasco M; Serra A; Campo E; Montserrat E
Sangre (Barc); 1998 Jun; 43(3):244-7. PubMed ID: 9741235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
